BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Zeng J, Gao Y, He D. Targeting silibinin in the antiproliferative pathway. Expert Opinion on Investigational Drugs 2010;19:243-55. [DOI: 10.1517/13543780903533631] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Shete MB, Deshpande AS, Shende P. Silybin-based herbal nanocarriers: an advancement in anticancer therapy. Materials Technology. [DOI: 10.1080/10667857.2022.2081286] [Reference Citation Analysis]
2 Addeo R. Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer. J Exp Pharmacol 2021;13:901-3. [PMID: 34611448 DOI: 10.2147/JEP.S326871] [Reference Citation Analysis]
3 Habán M, Zvercová D, Adamjaková M. Evaluation of variability of silymarin complex in Silybi mariani fructus harvested during two production years. European Pharmaceutical Journal 2021;68:40-5. [DOI: 10.2478/afpuc-2020-0023] [Reference Citation Analysis]
4 Kesharwani SS, Jain V, Dey S, Sharma S, Mallya P, Kumar VA. An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin. Journal of Drug Delivery Science and Technology 2020;60:102021. [DOI: 10.1016/j.jddst.2020.102021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fulvio F, Martinelli T, Paris R. Selection and validation of reference genes for RT-qPCR normalization in different tissues of milk thistle (Silybum marianum, Gaert.). Gene 2021;768:145272. [PMID: 33122080 DOI: 10.1016/j.gene.2020.145272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Durymanov M, Permyakova A, Reineke J. Pre-treatment With PLGA/Silibinin Nanoparticles Mitigates Dacarbazine-Induced Hepatotoxicity. Front Bioeng Biotechnol 2020;8:495. [PMID: 32671024 DOI: 10.3389/fbioe.2020.00495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Vargas-Mendoza N, Morales-González Á, Morales-Martínez M, Soriano-Ursúa MA, Delgado-Olivares L, Sandoval-Gallegos EM, Madrigal-Bujaidar E, Álvarez-González I, Madrigal-Santillán E, Morales-Gonzalez JA. Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications. Biomedicines 2020;8:E122. [PMID: 32423098 DOI: 10.3390/biomedicines8050122] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
8 Fan Y, Hou T, Dan W, Liu T, Luan J, Liu B, Li L, Zeng J. Silibinin inhibits epithelial‑mesenchymal transition of renal cell carcinoma through autophagy‑dependent Wnt/β‑catenin signaling. Int J Mol Med 2020;45:1341-50. [PMID: 32323735 DOI: 10.3892/ijmm.2020.4521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alipour M, Bigdeli M, Aligholi H, Rasoulian B, Khaksarian M. Sustained release of silibinin‐loaded chitosan nanoparticle induced apoptosis in glioma cells. J Biomed Mater Res 2020;108:458-69. [DOI: 10.1002/jbm.a.36827] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
10 Mao J, Yang H, Cui T, Pan P, Kabir N, Chen D, Ma J, Chen X, Chen Y, Yang Y. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT. Eur J Pharmacol 2018;832:39-49. [PMID: 29782854 DOI: 10.1016/j.ejphar.2018.05.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
11 Prack Mc Cormick B, Langle Y, Belgorosky D, Vanzulli S, Balarino N, Sandes E, Eiján AM. Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer. J Cell Biochem 2018;119:5402-12. [PMID: 29363820 DOI: 10.1002/jcb.26693] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
12 Amawi H, Ashby CR Jr, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what's limiting? Chin J Cancer 2017;36:50. [PMID: 28629389 DOI: 10.1186/s40880-017-0217-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 79] [Article Influence: 14.0] [Reference Citation Analysis]
13 Zhang B, Wang B, Cao S, Wang Y, Wu D. Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation. Int J Mol Med 2017;39:1111-8. [PMID: 28350048 DOI: 10.3892/ijmm.2017.2935] [Cited by in Crossref: 31] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
14 Chen YH, Chen CL, Lu DW, Liang CM, Tai MC, Chen JT. Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner. PLoS One 2016;11:e0168765. [PMID: 28030611 DOI: 10.1371/journal.pone.0168765] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
15 Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, Gu N, Wu J, Li W, Zhang Y, Zhou S, Sun H, Liu C. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer – A comprehensive review. European Journal of Medicinal Chemistry 2016;123:577-95. [DOI: 10.1016/j.ejmech.2016.07.070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
16 Kiyama R. Biological effects induced by estrogenic activity of lignans. Trends in Food Science & Technology 2016;54:186-96. [DOI: 10.1016/j.tifs.2016.06.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
17 Antoszczak M, Klejborowska G, Kruszyk M, Maj E, Wietrzyk J, Huczyński A. Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin. Chem Biol Drug Des 2015;86:1378-86. [PMID: 26058448 DOI: 10.1111/cbdd.12602] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
18 Bosch-Barrera J, Menendez JA. Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy. Cancer Treat Rev. 2015;41:540-546. [PMID: 25944486 DOI: 10.1016/j.ctrv.2015.04.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 11.4] [Reference Citation Analysis]
19 Surai PF. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives. Antioxidants (Basel) 2015;4:204-47. [PMID: 26785346 DOI: 10.3390/antiox4010204] [Cited by in Crossref: 227] [Cited by in F6Publishing: 231] [Article Influence: 32.4] [Reference Citation Analysis]
20 Wang Y, Liang W, Pan W, Law W, Hu J, Ip DT, Waye MM, Ng T, Wan DC. Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells. Phytomedicine 2014;21:1310-7. [DOI: 10.1016/j.phymed.2014.06.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
21 Chen YH, Chen CL, Liang CM, Liang JB, Tai MC, Chang YH, Lu DW, Chen JT. Silibinin inhibits ICAM-1 expression via regulation of N-linked and O-linked glycosylation in ARPE-19 cells. Biomed Res Int 2014;2014:701395. [PMID: 25032222 DOI: 10.1155/2014/701395] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Pooja D, Babu Bikkina DJ, Kulhari H, Nikhila N, Chinde S, Raghavendra YM, Sreedhar B, Tiwari AK. Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles. Int J Biol Macromol 2014;69:267-73. [PMID: 24863917 DOI: 10.1016/j.ijbiomac.2014.05.035] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
23 Gándara L, Sandes E, Di Venosa G, Prack Mc Cormick B, Rodriguez L, Mamone L, Batlle A, Eiján A, Casas A. The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells. Journal of Photochemistry and Photobiology B: Biology 2014;133:55-64. [DOI: 10.1016/j.jphotobiol.2014.03.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
24 Grillo C, Chichiarelli S, Gaucci E, Altieri F, Turano C, Cervoni L. The binding of silibinin to ERp57. Chem Biol Interact 2014;213:37-43. [PMID: 24530445 DOI: 10.1016/j.cbi.2014.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
25 Chen YH, Liang CM, Chen CL, Chen JT, Chang YH, Lu DW, Chien KH, Tai MC. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model. Acta Ophthalmol 2013;91:e506-15. [PMID: 23764119 DOI: 10.1111/aos.12160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
26 Wu K, Ning Z, Zeng J, Fan J, Zhou J, Zhang T, Zhang L, Chen Y, Gao Y, Wang B, Guo P, Li L, Wang X, He D. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Cell Signal 2013;25:2625-33. [PMID: 24012496 DOI: 10.1016/j.cellsig.2013.08.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 7.1] [Reference Citation Analysis]
27 Hu Y, Wang S, Wu X, Zhang J, Chen R, Chen M, Wang Y. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. J Ethnopharmacol. 2013;149:601-612. [PMID: 23916858 DOI: 10.1016/j.jep.2013.07.030] [Cited by in Crossref: 105] [Cited by in F6Publishing: 112] [Article Influence: 11.7] [Reference Citation Analysis]
28 Corchete P, Bru R. Proteome alterations monitored by DIGE analysis in Silybum marianum cell cultures elicited with methyl jasmonate and methyl B cyclodextrin. Journal of Proteomics 2013;85:99-108. [DOI: 10.1016/j.jprot.2013.04.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
29 Xue M, Zhang S, Cai C, Yu X, Shan L, Liu X, Zhang W, Li H. Predicting the Drug Safety for Traditional Chinese Medicine through a Comparative Analysis of Withdrawn Drugs Using Pharmacological Network. Evid Based Complement Alternat Med 2013;2013:256782. [PMID: 23737823 DOI: 10.1155/2013/256782] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal 2012;24:2291-6. [PMID: 22820499 DOI: 10.1016/j.cellsig.2012.07.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 7.2] [Reference Citation Analysis]
31 Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, Gong J, Zhong Z, Xu Z, Dang Y. Anti-cancer natural products isolated from chinese medicinal herbs. Chin Med. 2011;6:27. [PMID: 21777476 DOI: 10.1186/1749-8546-6- 27] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, Gong J, Zhong Z, Xu Z, Dang Y. Anti-cancer natural products isolated from chinese medicinal herbs. Chin Med. 2011;6:27. [PMID: 21777476 DOI: 10.1186/1749-8546-6-27] [Cited by in Crossref: 221] [Cited by in F6Publishing: 211] [Article Influence: 20.1] [Reference Citation Analysis]
33 Dunnick JK, Singh B, Nyska A, Peckham J, Kissling GE, Sanders JM. Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle. Toxicol Pathol 2011;39:398-409. [PMID: 21300790 DOI: 10.1177/0192623310394211] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
34 Deep G, Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev 2010;29:447-63. [PMID: 20714788 DOI: 10.1007/s10555-010-9237-0] [Cited by in Crossref: 149] [Cited by in F6Publishing: 138] [Article Influence: 12.4] [Reference Citation Analysis]
35 Li X, Su B, Liu R, Wu D, He D. Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Surg Res 2011;166:e45-51. [PMID: 21176918 DOI: 10.1016/j.jss.2010.10.034] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
36 Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res 2010;24:1423-32. [DOI: 10.1002/ptr.3207] [Cited by in Crossref: 289] [Cited by in F6Publishing: 279] [Article Influence: 24.1] [Reference Citation Analysis]